Merck & Co. said Friday that its experimental COVID-19 pill reduced hospitalizations and deaths by half in people recently infected with the coronavirus and that it would soon ask health officials in the U.S. and around the world to authorize its use.
from CBC | Health News https://ift.tt/3mhrD7L
Aucun commentaire:
Enregistrer un commentaire